Publications

Detailed Information

Allelic and Haplotypic Diversity of HLA-A, -B, -C, and-DRB1 Genes in Koreans Defined by High-resolution DNA Typing

DC Field Value Language
dc.contributor.authorChung, Hye Yoon-
dc.contributor.authorYoon, Jung Ah-
dc.contributor.authorSong, Eun Yung-
dc.contributor.authorHan, Bok Youn-
dc.contributor.authorPark, Myoung Hee-
dc.date.accessioned2012-05-24T00:45:32Z-
dc.date.available2012-05-24T00:45:32Z-
dc.date.issued2010-12-
dc.identifier.citationKOREAN JOURNAL OF LABORATORY MEDICINE; Vol.30 6; 685-696ko_KR
dc.identifier.issn1598-6535-
dc.identifier.urihttps://hdl.handle.net/10371/76368-
dc.description.abstract배경 : HLA 형별은 혈청학적 수준(generic level)에서도 다형성이 심하지만 대립유전자 수준에서는 더욱 심한 다형성을 보이고 인종 간에 큰 차이를 나타내는 것으로 알려졌다. 본 연구에서는 고해상도 DNA 검사법을 이용하여 한국인에서 HLA대립유전자 형별과 일배체형의 종류 및 빈도를 알아보고자 하였다. 방법 : 건강한 한국인 474명을 대상으로 HLA-A, -B, -C, -DRB1 유전자에 대해 두 단계의 검사로 대립유전자(4자리수)
형별 분석을 실시하였다. 1단계로 혈청학적 수준의 형별검사를 혈청학적 검사법이나 sequence-specific oligonucleotide(PCR-SSO) 방법으로 시행하였고, 그 다음 단계로 대립유전자 형별검사를 class I은 exon 2와 exon3, DRB1은 exon 2에 대해 single-strand conformation polymorphism (PCR-SSCP)
또는 직접염기서열분석법을 이용하여 실시하였다. HLA 대립 유전자의 유전자 빈도, 일배체형 빈도, 연쇄불평형 값은 maximum likelihood 원리에 근거한 제11차 국제조직적합성워크숍 컴퓨터 프로그램을 이용하여 산출하였다. 결과 : 한국인에서 검출된 HLA-A, -B, -C, DRB1 대립유전자 형별은 각각 21, 40, 22, 29종이었다. 이 중에 유전자 빈도 10% 이상을 보인 대립유전자 형별(빈도순 나열)은 A*02:01, A*24:02, A*33:03; B*51:01; C*01:02, C*03:03; RB1*09:01등이었다. HLA 일배체형의 분석 결과 0.5% 이상의 빈도를 나타내는 2-유전자좌 일배체형은 A-C 44종, B-C 42종, A-B 51종, B-DRB1 52종이었고, 3-유전자좌 일배체형은 A-C-B 42종, A-B-DRB1 34종이었다. 한국인에서 빈도 1% 이상의 A-B-DR 일배체형은 13종으로, 전체 일배체형의 26.0%를 차지하였고, 2% 이상으로 가장 흔한 A-B-DR 일배체형은 A*33:03-B*44:03-DRB1*13:02 (3.7%), A*33:03-B*44:03-DRB1*07:01 (3.0%), A*33:03-B*58:01-DRB1*13:02 (3.0%), A*24:02-B*07:02-DRB1*01:01 (2.8%), A*30:01-B*13:02-DRB1*
07:01 (2.3%), A*11:01-B*15:01-DRB1*04:06 (2.2%) 등 6종이었다. 결론 : 본 연구를 통해 한국인의 대립유전자 수준의 HLA 형별과 HLA 일배체형 빈도에 대한 자료를 제시하였으며, 본 연구의 결과는 한국인에서 장기이식, 질환연관성 연구, 인류유전학적 연구 등에서 중요한 기초자료로 이용될 수 있을 것으로 기대된다. Background : In this study, we used high-resolution DNA typing to investigate the distribution of HLA alleles and haplotypes in Koreans. Methods : HLA-A, -B, -C, and -DRB1 alleles were genotyped at the allelic (4-digit) level in 474 healthy Koreans. HLA genotyping was performed in two steps. Initially, serologic typing or generic-level DNA typing was performed using the FOR-sequence-specific oligonucleotide method, and then allelic DNA typing (exons 2 and 3 for class I, and exon 2 for DRB1) was carried out using the FOR-single-strand conformation polymorphism method or sequence-based typing. HLA allele and haplotype frequencies and linkage disequilibrium values were calculated by the maximum likelihood method using a computer program developed for the 11th International Histocompatibility Workshop. Results : A total of 21 HLA-A, 40 HLA-B, 22 HLA-C, and 29 HLA-DRB1 alleles were found in Koreans. The most frequent alleles in each locus with frequencies of >= 10% were, in decreasing order of frequency, as follows: A star 24:02, A star 02:01, A(star)33:03; B(star)51:01; C(star)01:02, C(star)03:03; and DRB1(star)09:01. The numbers of two- and three-locus haplotypes with frequencies of >0.5% were as follows: 44 A-C, 42 B-C, 51 A-B, 52 B-DRB1, 42 A-C-B, and 34 A-B-DRB1. Thirteen A-B-DRB1 haplotypes with frequencies of >= 1.0% comprised 26.0% of the total haplotypes. The six most common haplotypes were as follows: A(star)33:03-B(star)44:03-DRB1(star)3:02 (3.7%), A(star)33:03-B(star)44:03-DRB1(star)07:01 (3.0%), A(star)33:03-B(star)58: 01-DRB1(star)13:02 (3.0%), A(star)24:02-B(star)07:02-DRB1(star)01:01 (2.8%), A(star)30:01-B(star)13:02-DRB1(star)07:01 (2.3%), and A(star)11:01-B(star)15:01-DR81(star)04:06 (2.2%). Conclusions : The information obtained in this study can be used as basic data for Koreans in the fields of organ transplantation, disease association, and anthropologic studies. (Korean J Lab Med 2010;30:685-96)
ko_KR
dc.language.isokoko_KR
dc.publisherKOREAN SOC LABORATORY MEDICINEko_KR
dc.subjectHLAko_KR
dc.subjectKoreanko_KR
dc.subjectAlleleko_KR
dc.subjectDNA typingko_KR
dc.subjectHaplotypeko_KR
dc.titleAllelic and Haplotypic Diversity of HLA-A, -B, -C, and-DRB1 Genes in Koreans Defined by High-resolution DNA Typingko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor정혜윤-
dc.contributor.AlternativeAuthor송은영-
dc.contributor.AlternativeAuthor박명희-
dc.contributor.AlternativeAuthor한복연-
dc.contributor.AlternativeAuthor윤정아-
dc.identifier.doi10.3343/kjlm.2010.30.6.685-
dc.citation.journaltitleKOREAN JOURNAL OF LABORATORY MEDICINE-
dc.description.citedreferenceYoon JH, 2010, TISSUE ANTIGENS, V75, P170, DOI 10.1111/j.1399-0039.2009.01418.x-
dc.description.citedreferenceLee KW, 2009, HUM IMMUNOL, V70, P464, DOI 10.1016/j.humimm.2009.03.010-
dc.description.citedreferenceYang KL, 2009, HUM IMMUNOL, V70, P269, DOI 10.1016/j.humimm.2009.01.015-
dc.description.citedreferenceYI DY, 2009, KOREAN J LAB MED, V29, pS425-
dc.description.citedreferenceWhang DH, 2008, KOREAN J LAB MED, V28, P465, DOI 10.3343/kjlm.2008.28.6.465-
dc.description.citedreferenceTrachtenberg E, 2007, TISSUE ANTIGENS, V70, P455, DOI 10.1111/j.1399-0039.2007.00932.x-
dc.description.citedreferenceCano P, 2007, HUM IMMUNOL, V68, P392, DOI 10.1016/j.humimm.2007.01.014-
dc.description.citedreferenceYang G, 2006, TISSUE ANTIGENS, V67, P146, DOI 10.1111/j.1399-0039.2005.00529.x-
dc.description.citedreferenceMACK SJ, 2006, IMMUNOBIOLOGY HUMAN, V1, P291-
dc.description.citedreferenceItoh Y, 2005, IMMUNOGENETICS, V57, P717, DOI 10.1007/s00251-005-0048-3-
dc.description.citedreferenceLee KW, 2005, TISSUE ANTIGENS, V65, P437, DOI 10.1111/j.1399-0039.2005.00386.x-
dc.description.citedreferenceOttinger HD, 2004, TRANSPLANTATION, V78, P1077, DOI 10.1097/01.TP.0000137791.28140.93-
dc.description.citedreferenceFlomenberg N, 2004, BLOOD, V104, P1923, DOI 10.1182/blood-2004-03-0803-
dc.description.citedreferenceSong EY, 2004, HUM IMMUNOL, V65, P270, DOI 10.1016/j.humimm.2003.12.005-
dc.description.citedreferenceHWANG SH, 2004, KOREAN J LAB MED, V24, P396-
dc.description.citedreferenceROH EY, 2003, KOREAN J LAB MED, V23, P420-
dc.description.citedreferenceWHANG DH, 2003, KOREAN J LAB MED, V23, P52-
dc.description.citedreferenceLee KW, 2010, KOREAN J LAB MED, V30, P203, DOI 10.3343/kjlm.2010.30.3.203-
dc.description.citedreferenceMorishima Y, 2002, BLOOD, V99, P4200-
dc.description.citedreferenceSong EY, 2002, TISSUE ANTIGENS, V59, P475-
dc.description.citedreferenceSong EY, 2001, HUM IMMUNOL, V62, P1142-
dc.description.citedreferenceNAKAJIMA F, 2001, MHC, V8, P1-
dc.description.citedreferenceSaito S, 2000, TISSUE ANTIGENS, V56, P522-
dc.description.citedreferencePark MH, 2000, TISSUE ANTIGENS, V55, P250-
dc.description.citedreferenceDUNN P, 2000, IHWG TECHNICAL MANUA, P1-
dc.description.citedreferencePark MH, 1999, TISSUE ANTIGENS, V53, P386-
dc.description.citedreferenceMarsh SGE, 2010, TISSUE ANTIGENS, V75, P291-
dc.description.citedreferencePetersdorf EW, 1998, BLOOD, V92, P3515-
dc.description.citedreferencePark MH, 1998, TISSUE ANTIGENS, V51, P347-
dc.description.citedreferenceWang H, 1997, TISSUE ANTIGENS, V50, P620-
dc.description.citedreferenceCereb N, 1997, TISSUE ANTIGENS, V50, P74-
dc.description.citedreferenceBannai M, 1997, TISSUE ANTIGENS, V49, P376-
dc.description.citedreferenceBannai M, 1996, HUM IMMUNOL, V46, P107-
dc.description.citedreferenceCEREB N, 1995, TISSUE ANTIGENS, V45, P1-
dc.description.citedreferenceBANNAI M, 1994, EUR J IMMUNOGENET, V21, P1-
dc.description.citedreferenceIMANISHI T, 1992, HLA 1991, V1, P76-
dc.description.citedreferenceTOKUNAGA K, 1992, EVOLUTION DISPERSAL, P599-
dc.description.tc1-
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share